In direct response to patient advocacy campaigns highlighting unacceptable diagnostic delays, two non-invasive endometriosis screening tests are now accessible for deployment in primary care settings. This development marks a critical advancement in addressing the diagnostic bottleneck that has historically affected millions of patients globally, with diagnostic delays often extending years from initial symptom presentation to confirmed diagnosis.
The availability of these screening tools in general practice represents a fundamental shift away from the traditional specialist-dependent diagnostic pathway. By enabling frontline healthcare providers to conduct non-invasive screening, these tests remove barriers associated with delayed specialist referral and the need for surgical confirmation. The implementation of these tools in primary care protocols could accelerate diagnosis across diverse patient populations and reduce healthcare inequities in endometriosis management. Read the full article on GMJ Newsroom.
Was this article helpful?
